Sort
51,593 grants matching “hepatitis”
Novel therapy for alcoholic liver disease-associated hepatorenal syndrome
$1,500,000Mani Subramanian · Mitopower Llc · U44 · FY2023 · AA
Vanderbilt In Vivo Cellular and Molecular Imaging Center
$1,500,000John C Gore · Vanderbilt University · P50 · FY2009 · CA
SBIR PHASE II Point-of-Care HCV Detection
$1,500,000Hong Qi · Qoolabs, Inc. · N01 · FY2023 · AI
Novel therapy for alcoholic liver disease-associated hepatorenal syndrome
$1,500,000Mani Subramanian · Mitopower Llc · U44 · FY2024 · AA
California-Arizona Clinical Trials Network Node
$1,500,000University Of California San Francisco · U10 · FY2003 · DA
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
$1,500,000Steven E Shoelson · Joslin Diabetes Center · U01 · FY2010 · DK
California-Arizona Clinical Trials Network Node
$1,500,000University Of California San Francisco · U10 · FY2004 · DA
Integrating innate and adaptive pathways in vaccine responses
$1,500,000Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2021 · AI
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
$1,500,000Steven E Shoelson · Joslin Diabetes Center · U01 · FY2006 · DK
ANTIVIRAL DRUGS TO CURE CHRONIC HEPATITIS B VIRUS INFECTION
$1,499,999Yang-Yuan Zhang · Hbvtech · N01 · FY2022 · AI
Novel therapy for alcoholic liver disease-associated hepatorenal syndrome
$1,499,999Mani Subramanian · Mitopower Llc · U44 · FY2025 · AA
Rapid, Point-of-Care Diagnostics for Hepatitis C Virus
$1,499,998Erica Ungewitter · Baebies, Inc. · N43 · FY2022 · AI
Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE)
$1,499,278April Marie Young · University Of Kentucky · UH3 · FY2019 · DA
1/2 Sickel Cell Disease Treatment with Arginine Therapy (STArT Trial)
$1,497,960Claudia R Morris · Emory University · UH3 · FY2022 · HL
Early Pathogenesis of Cystic Fibrosis Related Diabetes
$1,497,916John F Engelhardt · University Of Iowa · R24 · FY2015 · DK
HIV Disease Outcomes in Drug Users in Clinical Practice
$1,496,559Richard Douglas Moore · Johns Hopkins University · U01 · FY2017 · DA
HIV Disease Outcomes in Drug Users in Clinical Practice
$1,496,559Richard Douglas Moore · Johns Hopkins University · U01 · FY2019 · DA
Role of Tim Family Genes in Asthma and Allergic Diseases
$1,496,316Dale T Umetsu · Boston Children'S Hospital · P01 · FY2007 · AI
Alcohol Associated Outcomes Among HIV+/-Aging Veterans
$1,496,218University Of Pittsburgh At Pittsburgh · R01 · FY2001 · AA
MIAMI ADULT AIDS CLINICAL TRIALS GROUP, AACTG
$1,496,173University Of Miami School Of Medicine · U01 · FY2005 · AI
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
$1,496,150Andrea Lynne Gropman · Children'S Research Institute · U54 · FY2023 · HD
University of Washington Interdisciplinary Center for Exposures, Diseases, Genomics & Environment
$1,495,739Joel Daniel Kaufman · University Of Washington · P30 · FY2023 · ES
Stellenbosch University Clinical Trials Unit
$1,495,502Anneke Catharina Hesseling · Stellenbosch University · UM1 · FY2025 · AI
A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients (THINKER-NEXT)
$1,493,330Peter Philip Reese · University Of Pennsylvania · U01 · FY2022 · DK
Molecular Regulation Of RNA Metabolism
$1,493,315Richard J Maraia · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD